{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T16:21:39Z","timestamp":1778170899261,"version":"3.51.4"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Project of Shanghai Municipal Health Commission","award":["202140472"],"award-info":[{"award-number":["202140472"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-23707-3","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T11:49:51Z","timestamp":1763552991000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Smurf1 promotes gastric cancer progression by regulating Axin2-dependent Wnt signaling pathway"],"prefix":"10.1038","volume":"15","author":[{"given":"Jinling","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiachen","family":"Jing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhonghua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beina","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuo","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"23707_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"23707_CR2","doi-asserted-by":"crossref","unstructured":"Yang, K. et al. Real-world Outcomes of Regorafenib Combined with Immune Checkpoint Inhibitors in Patients with Advanced or Metastatic Microsatellite Stable Colorectal Cancer: A Multicenter Study (CII, 2021).","DOI":"10.1007\/s00262-021-03083-3"},{"key":"23707_CR3","first-page":"249","volume":"14","author":"L Herszenyi","year":"2010","unstructured":"Herszenyi, L. & Tulassay, Z. Epidemiology of Gastrointestinal and liver tumors. Eur. Rev. Med. Pharmacol. Sci. 14, 249\u2013258 (2010).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"23707_CR4","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/978-1-60327-492-0_23","volume":"472","author":"H Brenner","year":"2009","unstructured":"Brenner, H., Rothenbacher, D. & Arndt, V. Epidemiology of stomach cancer. Methods Mol. Biol. 472, 467\u2013477 (2009).","journal-title":"Methods Mol. Biol."},{"key":"23707_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.tim.2003.11.005","volume":"12","author":"M Naumann","year":"2004","unstructured":"Naumann, M. & Crabtree, J. E. Helicobacter pylori-induced epithelial cell signalling in gastric carcinogenesis. Trends Microbiol. 12, 29\u201336 (2004).","journal-title":"Trends Microbiol."},{"key":"23707_CR6","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.semcancer.2019.12.023","volume":"67","author":"L Fu","year":"2020","unstructured":"Fu, L., Cui, C. P., Zhang, X. & Zhang, L. The functions and regulation of smurfs in cancers. Sem. Cancer Biol. 67, 102\u2013116 (2020).","journal-title":"Sem. Cancer Biol."},{"key":"23707_CR7","doi-asserted-by":"publisher","first-page":"23084","DOI":"10.1074\/jbc.M709848200","volume":"283","author":"R Guo","year":"2008","unstructured":"Guo, R. et al. Ubiquitin ligase Smurf1 mediates tumor necrosis factor-induced systemic bone loss by promoting proteasomal degradation of bone morphogenetic signaling proteins. J. Biol. Chem. 283, 23084\u201323092 (2008).","journal-title":"J. Biol. Chem."},{"key":"23707_CR8","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.cell.2005.01.035","volume":"121","author":"M Yamashita","year":"2005","unstructured":"Yamashita, M. et al. Ubiquitin ligase Smurf1 controls osteoblast activity and bone homeostasis by targeting MEKK2 for degradation. Cell 121, 101\u2013113 (2005).","journal-title":"Cell"},{"key":"23707_CR9","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1083\/jcb.201609073","volume":"216","author":"X Wei","year":"2017","unstructured":"Wei, X. et al. Smurf1 inhibits integrin activation by controlling Kindlin-2 ubiquitination and degradation. J. Cell. Biol. 216, 1455\u20131471 (2017).","journal-title":"J. Cell. Biol."},{"key":"23707_CR10","doi-asserted-by":"publisher","first-page":"4095","DOI":"10.1128\/MCB.00418-13","volume":"33","author":"C Fei","year":"2013","unstructured":"Fei, C. et al. Smurf1-mediated Lys29-linked nonproteolytic polyubiquitination of Axin negatively regulates Wnt\/beta-catenin signaling. Mol. Cell. Biol. 33, 4095\u20134105 (2013).","journal-title":"Mol. Cell. Biol."},{"key":"23707_CR11","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.3892\/or.2017.5825","volume":"38","author":"Y Tao","year":"2017","unstructured":"Tao, Y., Sun, C., Zhang, T. & Song, Y. SMURF1 promotes the proliferation, migration and invasion of gastric cancer cells. Oncol. Rep. 38, 1806\u20131814 (2017).","journal-title":"Oncol. Rep."},{"key":"23707_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","volume":"7","author":"J Liu","year":"2022","unstructured":"Liu, J. et al. Wnt\/beta-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal. Transduct. Target. Therapy. 7, 3 (2022).","journal-title":"Signal. Transduct. Target. Therapy"},{"key":"23707_CR13","doi-asserted-by":"publisher","first-page":"116920","DOI":"10.1016\/j.bmc.2022.116920","volume":"70","author":"EMR Koelman","year":"2022","unstructured":"Koelman, E. M. R., Yeste-Vazquez, A. & Grossmann, T. N. Targeting the interaction of beta-catenin and TCF\/LEF transcription factors to inhibit oncogenic Wnt signaling. Bioorg. Med. Chem. 70, 116920 (2022).","journal-title":"Bioorg. Med. Chem."},{"key":"23707_CR14","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.pharmthera.2018.02.009","volume":"187","author":"W Skronska-Wasek","year":"2018","unstructured":"Skronska-Wasek, W., Gosens, R., Konigshoff, M. & Baarsma, H. A. WNT receptor signalling in lung physiology and pathology. Pharmacol. Ther. 187, 150\u2013166 (2018).","journal-title":"Pharmacol. Ther."},{"key":"23707_CR15","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1161\/CIRCRESAHA.110.223750","volume":"107","author":"E Dejana","year":"2010","unstructured":"Dejana, E. The role of Wnt signaling in physiological and pathological angiogenesis. Circul. Res. 107, 943\u2013952 (2010).","journal-title":"Circul. Res."},{"key":"23707_CR16","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nm.3074","volume":"19","author":"R Baron","year":"2013","unstructured":"Baron, R. & Kneissel, M. WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat. Med. 19, 179\u2013192 (2013).","journal-title":"Nat. Med."},{"key":"23707_CR17","doi-asserted-by":"publisher","first-page":"e756","DOI":"10.1002\/onco.13695","volume":"26","author":"P Yu","year":"2021","unstructured":"Yu, P. et al. Deep targeted sequencing and its potential implication for cancer therapy in Chinese patients with gastric adenocarcinoma. Oncologist 26, e756\u2013e768 (2021).","journal-title":"Oncologist"},{"key":"23707_CR18","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.tcb.2018.08.005","volume":"29","author":"L Galluzzi","year":"2019","unstructured":"Galluzzi, L., Spranger, S., Fuchs, E. & Lopez-Soto, A. WNT signaling in cancer immunosurveillance. Trends Cell Biol. 29, 44\u201365 (2019).","journal-title":"Trends Cell Biol."},{"key":"23707_CR19","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1158\/1541-7786.MCR-20-0180","volume":"18","author":"S Li","year":"2020","unstructured":"Li, S. et al. Wnt\/beta-Catenin signaling axis is required for TFEB-Mediated gastric cancer metastasis and Epithelial-Mesenchymal transition. Mol. Cancer Res. 18, 1650\u20131659 (2020).","journal-title":"Mol. Cancer Res."},{"key":"23707_CR20","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1158\/0008-5472.CAN-22-3518","volume":"83","author":"S Matsumoto","year":"2023","unstructured":"Matsumoto, S. et al. Wnt signaling stimulates Cooperation between GREB1 and HNF4alpha to promote proliferation in hepatocellular carcinoma. Cancer Res. 83, 2312\u20132327 (2023).","journal-title":"Cancer Res."},{"key":"23707_CR21","doi-asserted-by":"publisher","first-page":"193","DOI":"10.47717\/turkjsurg.2021.4973","volume":"37","author":"A Isik","year":"2021","unstructured":"Isik, A. & Firat, D. Letter to the editor concerning most cited 100 articles from Turkey on abdominal wall hernias: a bibliometric study. Turk. J. Surg. 37, 193\u2013194 (2021).","journal-title":"Turk. J. Surg."},{"key":"23707_CR22","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1124\/pr.57.2.5","volume":"57","author":"SM Foord","year":"2005","unstructured":"Foord, S. M. et al. International union of Pharmacology. XLVI. G protein-coupled receptor list. Pharmacol. Rev. 57, 279\u2013288 (2005).","journal-title":"Pharmacol. Rev."},{"key":"23707_CR23","doi-asserted-by":"crossref","unstructured":"Reyes, M., Flores, T., Betancur, D., Pena-Oyarzun, D. & Torres, V. A. Wnt\/beta-Catenin signaling in oral carcinogenesis. Int. J. Mol. Sci. 21, (2020).","DOI":"10.3390\/ijms21134682"},{"key":"23707_CR24","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.cell.2006.10.018","volume":"127","author":"H Clevers","year":"2006","unstructured":"Clevers, H. Wnt\/beta-catenin signaling in development and disease. Cell 127, 469\u2013480 (2006).","journal-title":"Cell"},{"key":"23707_CR25","doi-asserted-by":"publisher","first-page":"858782","DOI":"10.3389\/fonc.2022.858782","volume":"12","author":"K Shah","year":"2022","unstructured":"Shah, K. & Kazi, J. U. Phosphorylation-Dependent regulation of WNT\/Beta-Catenin signaling. Front. Oncol. 12, 858782 (2022).","journal-title":"Front. Oncol."},{"key":"23707_CR26","doi-asserted-by":"crossref","unstructured":"Jing, J. C. et al. KDM4B promotes gastric cancer metastasis by regulating miR-125b-mediated activation of Wnt signaling. J. Cell. Biochem., (2018).","DOI":"10.1002\/jcb.28065"},{"key":"23707_CR27","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.molcel.2016.08.026","volume":"64","author":"MV Gammons","year":"2016","unstructured":"Gammons, M. V., Renko, M., Johnson, C. M., Rutherford, T. J. & Bienz, M. Wnt signalosome assembly by DEP domain swapping of dishevelled. Mol. Cell. 64, 92\u2013104 (2016).","journal-title":"Mol. Cell"},{"key":"23707_CR28","doi-asserted-by":"publisher","first-page":"14170","DOI":"10.1074\/jbc.M113.536714","volume":"289","author":"C Fei","year":"2014","unstructured":"Fei, C. et al. Smurf1-mediated Axin ubiquitination requires Smurf1 C2 domain and is cell cycle-dependent. J. Biol. Chem. 289, 14170\u201314177 (2014).","journal-title":"J. Biol. Chem."},{"key":"23707_CR29","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1006\/abio.1999.4085","volume":"270","author":"J Winer","year":"1999","unstructured":"Winer, J., Jung, C. K., Shackel, I. & Williams, P. M. Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal. Biochem. 270, 41\u201349 (1999).","journal-title":"Anal. Biochem."},{"key":"23707_CR30","doi-asserted-by":"publisher","first-page":"e3001361","DOI":"10.1371\/journal.pbio.3001361","volume":"19","author":"W Zhang","year":"2021","unstructured":"Zhang, W. et al. A conserved ubiquitin- and ESCRT-dependent pathway internalizes human lysosomal membrane proteins for degradation. PLoS Biol. 19, e3001361 (2021).","journal-title":"PLoS Biol."},{"key":"23707_CR31","doi-asserted-by":"publisher","first-page":"4575","DOI":"10.1016\/j.febslet.2010.10.008","volume":"584","author":"K Tano","year":"2010","unstructured":"Tano, K. et al. MALAT-1 enhances cell motility of lung adenocarcinoma cells by influencing the expression of motility-related genes. FEBS Lett. 584, 4575\u20134580 (2010).","journal-title":"FEBS Lett."},{"key":"23707_CR32","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1111\/cas.13601","volume":"109","author":"W Feng","year":"2018","unstructured":"Feng, W. et al. Kruppel-like factor 4 promotes c-Met amplification-mediated gefitinib resistance in non-small-cell lung cancer. Cancer Sci. 109, 1775\u20131786 (2018).","journal-title":"Cancer Sci."},{"key":"23707_CR33","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.pathophys.2017.02.006","volume":"24","author":"DM Badary","year":"2017","unstructured":"Badary, D. M., Abdel-Wanis, M. E., Hafez, M. Z. & Aboulhagag, N. A. Immunohistochemical analysis of PTEN, HER2\/neu, and ki67 expression in patients with gastric cancer and their association with survival. Pathophysiology 24, 99\u2013106 (2017).","journal-title":"Pathophysiology"},{"key":"23707_CR34","doi-asserted-by":"publisher","first-page":"112277","DOI":"10.1016\/j.yexcr.2020.112277","volume":"396","author":"J Liu","year":"2020","unstructured":"Liu, J. et al. Human papillomavirus type 16 E7 oncoprotein-induced upregulation of lysine-specific demethylase 5A promotes cervical cancer progression by regulating the microRNA-424-5p\/suppressor of Zeste 12 pathway. Exp. Cell. Res. 396, 112277 (2020).","journal-title":"Exp. Cell. Res."},{"key":"23707_CR35","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/s41388-020-01572-w","volume":"40","author":"Z Yu","year":"2021","unstructured":"Yu, Z. et al. A novel UBE2T inhibitor suppresses Wnt\/beta-catenin signaling hyperactivation and gastric cancer progression by blocking RACK1 ubiquitination. Oncogene 40, 1027\u20131042 (2021).","journal-title":"Oncogene"},{"key":"23707_CR36","doi-asserted-by":"publisher","first-page":"5901","DOI":"10.1158\/0008-5472.CAN-19-1362","volume":"79","author":"DJ Flanagan","year":"2019","unstructured":"Flanagan, D. J., Vincan, E. & Phesse, T. J. Wnt signaling in cancer: not a binary ON:OFF switch. Cancer Res. 79, 5901\u20135906 (2019).","journal-title":"Cancer Res."},{"key":"23707_CR37","doi-asserted-by":"publisher","first-page":"641304","DOI":"10.3389\/fonc.2021.641304","volume":"11","author":"J Sun","year":"2021","unstructured":"Sun, J. et al. The sensitivity prediction of neoadjuvant chemotherapy for gastric cancer. Front. Oncol. 11, 641304 (2021).","journal-title":"Front. Oncol."},{"key":"23707_CR38","doi-asserted-by":"publisher","first-page":"927119","DOI":"10.3389\/fonc.2022.927119","volume":"12","author":"J Chen","year":"2022","unstructured":"Chen, J. et al. Neoadjuvant chemoradiotherapy for resectable gastric cancer: A meta-analysis. Front. Oncol. 12, 927119 (2022).","journal-title":"Front. Oncol."},{"key":"23707_CR39","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41419-018-1262-x","volume":"10","author":"M Jiang","year":"2019","unstructured":"Jiang, M. et al. miR-1254 inhibits cell proliferation, migration, and invasion by down-regulating Smurf1 in gastric cancer. Cell Death Dis. 10, 32 (2019).","journal-title":"Cell Death Dis."},{"key":"23707_CR40","doi-asserted-by":"publisher","first-page":"7623","DOI":"10.2147\/OTT.S208275","volume":"12","author":"L Lu","year":"2019","unstructured":"Lu, L. et al. MicroRNA-424 regulates cisplatin resistance of gastric cancer by targeting SMURF1 based on GEO database and primary validation in human gastric cancer tissues. OncoTargets Therapy. 12, 7623\u20137636 (2019).","journal-title":"OncoTargets Therapy"},{"key":"23707_CR41","doi-asserted-by":"publisher","first-page":"101307","DOI":"10.1016\/j.jbc.2021.101307","volume":"297","author":"MG Du","year":"2021","unstructured":"Du, M. G. et al. Neddylation modification of the U3 snoRNA-binding protein RRP9 by Smurf1 promotes tumorigenesis. J. Biol. Chem. 297, 101307 (2021).","journal-title":"J. Biol. Chem."},{"key":"23707_CR42","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/s41417-020-00255-8","volume":"28","author":"Q Xia","year":"2021","unstructured":"Xia, Q., Li, Y., Han, D. & Dong, L. SMURF1, a promoter of tumor cell progression? Cancer Gene Ther. 28, 551\u2013565 (2021).","journal-title":"Cancer Gene Ther."},{"key":"23707_CR43","doi-asserted-by":"crossref","unstructured":"Chen, J. et al. Effects of the Wnt\/beta-Catenin Signaling Pathway on Proliferation and Apoptosis of Gastric Cancer Cells. Contrast media & molecular imaging. : : 5132691, 2022. (2022).","DOI":"10.1155\/2022\/5132691"},{"key":"23707_CR44","doi-asserted-by":"crossref","unstructured":"Qi, J. et al. Targeting Wnt\/beta-Catenin signaling by TET1\/FOXO4 inhibits metastatic spreading and Self-Renewal of cancer stem cells in gastric cancer. Cancers 14, (2022).","DOI":"10.3390\/cancers14133232"},{"key":"23707_CR45","doi-asserted-by":"crossref","unstructured":"Tang, W. et al. The miR-3648\/FRAT1-FRAT2\/c-Myc negative feedback loop modulates the metastasis and invasion of gastric cancer cells. Oncogene, (2022).","DOI":"10.1038\/s41388-022-02451-2"},{"key":"23707_CR46","doi-asserted-by":"publisher","first-page":"101895","DOI":"10.1016\/j.tice.2022.101895","volume":"78","author":"W Liang","year":"2022","unstructured":"Liang, W., Zhang, T., Huo, J. & Yang, J. MARCH1 promotes the growth and maintaining of stem cell-like characteristics of gastric cancer cells by activating the Wnt\/beta-catenin signaling pathway. Tissue cell. 78, 101895 (2022).","journal-title":"Tissue cell."},{"key":"23707_CR47","doi-asserted-by":"crossref","unstructured":"Nong, J. et al. Phase separation of Axin organizes the beta-catenin destruction complex. J. Cell Biol. 220, (2021).","DOI":"10.1083\/jcb.202012112"},{"key":"23707_CR48","first-page":"8247","volume":"61","author":"R Wu","year":"2001","unstructured":"Wu, R., Zhai, Y., Fearon, E. R. & Cho, K. R. Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas. Cancer Res. 61, 8247\u20138255 (2001).","journal-title":"Cancer Res."},{"key":"23707_CR49","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13048-019-0596-z","volume":"12","author":"VHL Nguyen","year":"2019","unstructured":"Nguyen, V. H. L., Hough, R., Bernaudo, S. & Peng, C. Wnt\/beta-catenin signalling in ovarian cancer: insights into its hyperactivation and function in tumorigenesis. J. Ovarian Res. 12, 122 (2019).","journal-title":"J. Ovarian Res."},{"key":"23707_CR50","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.humpath.2008.06.006","volume":"40","author":"MS Kim","year":"2009","unstructured":"Kim, M. S., Kim, S. S., Ahn, C. H., Yoo, N. J. & Lee, S. H. Frameshift mutations of Wnt pathway genes AXIN2 and TCF7L2 in gastric carcinomas with high microsatellite instability. Hum. Pathol. 40, 58\u201364 (2009).","journal-title":"Hum. Pathol."},{"key":"23707_CR51","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1053\/j.gastro.2023.04.032","volume":"165","author":"J Zhai","year":"2023","unstructured":"Zhai, J. et al. ALKBH5 drives immune suppression via targeting AXIN2 to promote colorectal cancer and is a target for boosting immunotherapy. Gastroenterology 165, 445\u2013462 (2023).","journal-title":"Gastroenterology"},{"key":"23707_CR52","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41419-018-1263-9","volume":"10","author":"J Yu","year":"2019","unstructured":"Yu, J. et al. CDX2 inhibits the proliferation and tumor formation of colon cancer cells by suppressing Wnt\/beta-catenin signaling via transactivation of GSK-3beta and Axin2 expression. Cell. Death Dis. 10, 26 (2019).","journal-title":"Cell. Death Dis."},{"key":"23707_CR53","doi-asserted-by":"publisher","first-page":"293","DOI":"10.15252\/emmm.201606773","volume":"9","author":"G Picco","year":"2017","unstructured":"Picco, G. et al. Loss of AXIN1 drives acquired resistance to WNT pathway Blockade in colorectal cancer cells carrying RSPO3 fusions. EMBO Mol. Med. 9, 293\u2013303 (2017).","journal-title":"EMBO Mol. Med."},{"key":"23707_CR54","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1093\/carcin\/bgaa098","volume":"42","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y. et al. UBE3C promotes proliferation and inhibits apoptosis by activating the beta-catenin signaling via degradation of AXIN1 in gastric cancer. Carcinogenesis 42, 285\u2013293 (2021).","journal-title":"Carcinogenesis"},{"key":"23707_CR55","doi-asserted-by":"crossref","unstructured":"Lee, E., Salic, A., Kruger, R., Heinrich, R. & Kirschner, M. W. The roles of APC and Axin derived from experimental and theoretical analysis of the Wnt pathway. PLoS biology 1: E10, (2003).","DOI":"10.1371\/journal.pbio.0000010"},{"key":"23707_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2014.09.018","volume":"355","author":"SM Mazzoni","year":"2014","unstructured":"Mazzoni, S. M. & Fearon, E. R. AXIN1 and AXIN2 variants in Gastrointestinal cancers. Cancer Lett. 355, 1\u20138 (2014).","journal-title":"Cancer Lett."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23707-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23707-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23707-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T13:03:32Z","timestamp":1763557412000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23707-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["23707"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-23707-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6694191\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"assertion":[{"value":"19 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. The study was conducted in accordance with the Declaration of Helsinki (as revised in 2013). The study was approved by committee for the Protection of Human Subjects board of XuHui District Center Hospital in the approval (NO. 2022052) and informed consent was obtained from all individual participants in accordance with the ARRIVE guiding to minimize animal suffering. Nine weeks later, mice were euthanized by pentobarbital overdose. All methods were carried out in accordance with relevant guidelines and regulations. All methods are reported in accordance with ARRIVE guidelines (\n                      \n                      ).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"was obtained from all individual participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors have completed the CONSANT reporting checklist.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Reporting checklist"}}],"article-number":"40684"}}